What You Should Know:
– NANO-X IMAGING LTD has announced an agreement to acquire VasoHealthcare IT (VHC IT) from Vaso Corporation for up to $800k.
– The strategic acquisition is intended to accelerate the deployment of Nanox’s FDA-cleared AI solutions across U.S. healthcare facilities.
Integrating HIT Expertise for Chronic Disease Detection
VHC IT is a healthcare information technology provider that currently serves hospitals and healthcare providers across the United States. The integration will combine VHC IT’s established operational and customer-support infrastructure with Nanox.AI’s FDA-cleared AI solutions. These AI solutions analyze routine CT scans specifically for indicators of chronic diseases.
VHC IT’s expertise spans crucial implementation capabilities, including healthcare systems integration, workflow optimization, data migration, user training, and nationwide go-live support for medical imaging. This expertise is expected to support Nanox’s U.S. commercial expansion, enabling faster deployment and adoption while reducing time-to-value for healthcare providers.
Financial Terms of the Transaction
Under the terms of the proposed transaction, Nanox will acquire VHC IT for a total consideration of up to $800,000. The payment structure is based on performance:
- Initial Payment: $200,000 cash payment at closing.
- Earnouts: Up to $600,000 in performance-based earnout payments over a period of up to two years, contingent upon revenue retention targets with respect to existing customers.
“As we scale our AI business in the U.S., deployment pace and implementation quality are critical to success,” said Erez Meltzer, CEO and Acting Chairman of Nanox. “Bringing these capabilities in-house will allow us to control the entire customer experience—from software delivery through go-live support. This acquisition will accelerate our ability to onboard new customers quickly and efficiently.”
